Update on B:2367047 Rovacor Tablets 20mg (Lovastatin) SIN 10531P

Ranbaxy, would like to update healthcare professionals on the findings of the recent investigations into the incident involving the discovery of Vamlo (Amlodipine) Tablets being found in a batch of Rovacor Tablets 20mg. Ranbaxy has conducted and completed the root cause investigation for the incident of the tablets mix-up. Investigations have identified that the root cause to be the improper cleaning and verification of the bins for blister collection used during the manufacturing process. Ranbaxy has implemented the necessary corrective actions to avoid the future occurrence of such incidents. Please refer to the letter for further details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.